Kyoto University Hospital：Announcement of physician-initiated clinical trials for Parkinson’s disease

By IPS, Medical science

Kyoto University Hospital：Announcement of physician-initiated clinical trials for Parkinson’s disease

Kyoto University Hospital, in partnership with the Center for iPS Cell Research and Application (CiRA), Kyoto University, has planned physician-initiated clinical trials for Parkinson’s disease that transplants dopaminergic progenitors1 generated from induced pluripotent stem (iPS) cells. The clinical trial notification was submitted to the Pharmaceutical and Medical Devices Agency (PMDA; the Japanese equivalent of the FDA) on June 4, 2018, and the clinical trials are scheduled to begin on August 1 this year.

http://www.cira.kyoto-u.ac.jp/e/pressrelease/news/180730-170000.html

More from tokioX :

  1. Kyoto Univ: Providing “clinical IPS cells” overseas: Korean venture company
  2. Kyoto University: Identifies genes related to Alzheimer’s disease with iPS:
  3. Kyoto University: Reproduce intractable disease ALS with iPS cells: Therapeutic drug “Bosutinib”
  4. iPS drug discovery: The world’s first clinical trial of Alzheimer’s disease: 7 hospitals at Kyoto /Mie Univ
  5. Kyoto Univ: Knee cartilage regeneration with iPS cells: Clinical research approval
  6. Kyoto Univ’s Center for iPS Cell Research and Application, Sumitomo Chemical, and Sumitomo Dainippon Pharma Commence Joint Research on Producing Higher-Quality iPS Cells for Clinical Use
  7. Cancer Therapy: Kyoto University, New Method Detecting Aggressively Attacking Cancer Cells – Human iPS-derived “Killer T Cells”